NCT07555314 Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Series.
| NCT ID | NCT07555314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Warsaw |
| Condition | Midline Catheter |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2026-04-20 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will assess the efficacy, safety and practicality of using midline catheters for repeated intravenous lidocaine infusions in an outpatient pain management setting. Adult patients requiring serial lidocaine infusions for chronic pain will be enrolled and receive treatment through midline catheters over ten sessions. The study will investigate if the midline catheters are a safe and effective option for delivering repeated lidocaine infusions in the outpatient setting, offering a balance between ease of placement, acceptable complication risk and good patients' comfort.
Eligibility Criteria
Inclusion Criteria: * Patients qualified for lidocaine infusion therapy due to the chronic pain * Able to provide consent * ≥18 years of age Exclusion Criteria: * Lack of patient consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07555314 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Midline Catheter. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07555314 currently recruiting?
Yes, NCT07555314 is actively recruiting participants. Contact the research team at piotr.mieszczanski@wum.edu.pl for enrollment information.
Where is the NCT07555314 trial being conducted?
This trial is being conducted at Warsaw, Poland.
Who is sponsoring the NCT07555314 clinical trial?
NCT07555314 is sponsored by Medical University of Warsaw. The trial plans to enroll 500 participants.